Abilify and Omnaris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Omnaris (ciclesonide). Common drug interactions include back pain among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Omnaris. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

On Jul, 26, 2026

19 people who take Abilify and Omnaris together, and have interactions are studied.

What are the common drug interactions of Abilify and Omnaris, by gender? *:

female:

Back pain
Headache (pain in head)
Hypersensitivity
Oropharyngeal pain
Affective disorder (mental disorder)
Asthma
Blood pressure increased
Chest discomfort
Cough
Drug ineffective

male:

Anxiety
Chronic kidney disease
Gout (uric acid crystals building up in the body)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Panic attack
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Abilify and Omnaris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Affective disorder (mental disorder)
Asthma
Back pain
Blood pressure increased
Chest discomfort
Cough
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Forced expiratory volume decreased (decreased lung expired air volume)
Headache (pain in head)

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Anxiety
Gout (uric acid crystals building up in the body)
Influenza
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Panic attack
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Hypersensitivity

50-59:

Back pain
Influenza
Infusion related reaction
Local swelling (swelling at the site of some application of substance or injury)
Poor peripheral circulation
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

60+:

Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Rash
Vertigo
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Drug hypersensitivity
Ear discomfort
Headache (pain in head)
Hearing impaired
Nerve injury
Restless legs syndrome (a powerful urge to move your legs)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 57.89%
Asthma: 8 people, 42.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 31.58%
Pain: 6 people, 31.58%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 5 people, 26.32%
Type 2 Diabetes: 5 people, 26.32%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 15.79%
High Blood Cholesterol: 3 people, 15.79%
Headache (pain in head): 3 people, 15.79%
Hypersensitivity: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Omnaris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously